Global and United States Insulin Like Growth Factor I In-Depth Research Report 2017-2022

Published: Dec, 2017 | Pages: 103 | Publisher: US Market Insight (UMI)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Insulin Like Growth Factor I industry.

Major Companies
    Boehringer Ingelheim GmbH
    Genervon Biopharmaceuticals LLC
    MedImmune LLC
    Regulaxis SAS
    ...

Key Regions
    North America
        United States
            California
            Texas
            New York
            Others
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Insulin Like Growth Factor I Market, byGB-845
Insulin Like Growth Factor I Market, bysigitumab
Insulin Like Growth Factor I Market, by-6
Insulin Like Growth Factor I Market, by610.27
Insulin Like Growth Factor I Market, by630

Insulin Like Growth Factor I Market, by Key Consumers
    Alzheimer's Disease
    Breast Cancer
    Huntington Disease
    Muscular Dystrophy
    Others

 Table of Contents

Global and United States Insulin Like Growth Factor I In-Depth Research Report 2017-2022
Chapter One Global Insulin Like Growth Factor I Market Overview
    1.1 Global Insulin Like Growth Factor I Market Sales Volume Revenue and Price 2012-2017
    1.2 Insulin Like Growth Factor I, by B-845 2012-2017
        1.2.1 Global Insulin Like Growth Factor I Sales Market Share by B-845 2012-2017
        1.2.2 Global Insulin Like Growth Factor I Revenue Market Share by B-845 2012-2017
        1.2.3 Global Insulin Like Growth Factor I Price by B-845 2012-2017
        1.2.4 
        1.2.5 
    1.3 Insulin Like Growth Factor I, by igitumab 2012-2017
        1.3.1 Global Insulin Like Growth Factor I Sales Market Share by igitumab 2012-2017
        1.3.2 Global Insulin Like Growth Factor I Revenue Market Share by igitumab 2012-2017
        1.3.3 Global Insulin Like Growth Factor I Price by igitumab 2012-2017
        1.3.4 
        1.3.5 
    1.4 Insulin Like Growth Factor I, by 6 2012-2017
        1.4.1 Global Insulin Like Growth Factor I Sales Market Share by 6 2012-2017
        1.4.2 Global Insulin Like Growth Factor I Revenue Market Share by 6 2012-2017
        1.4.3 Global Insulin Like Growth Factor I Price by 6 2012-2017
        1.4.4 
        1.4.5 
    1.5 Insulin Like Growth Factor I, by 10.27 2012-2017
        1.5.1 Global Insulin Like Growth Factor I Sales Market Share by 10.27 2012-2017
        1.5.2 Global Insulin Like Growth Factor I Revenue Market Share by 10.27 2012-2017
        1.5.3 Global Insulin Like Growth Factor I Price by 10.27 2012-2017
        1.5.4 
        1.5.5 
    1.6 Insulin Like Growth Factor I, by 30 2012-2017
        1.6.1 Global Insulin Like Growth Factor I Sales Market Share by 30 2012-2017
        1.6.2 Global Insulin Like Growth Factor I Revenue Market Share by 30 2012-2017
        1.6.3 Global Insulin Like Growth Factor I Price by 30 2012-2017
        1.6.4 
        1.6.5 

Chapter Two United States Insulin Like Growth Factor I Market Overview
    2.1 United States Insulin Like Growth Factor I Market Sales Volume Revenue and Price 2012-2017
    2.2 Insulin Like Growth Factor I, by B-845 2012-2017
        2.2.1 United States Insulin Like Growth Factor I Sales Market Share by B-845 2012-2017
        2.2.2 United States Insulin Like Growth Factor I Revenue Market Share by B-845 2012-2017
        2.2.3 United States Insulin Like Growth Factor I Price by B-845 2012-2017
        2.2.4 
        2.2.5 
    2.3 Insulin Like Growth Factor I, by igitumab 2012-2017
        2.3.1 United States Insulin Like Growth Factor I Sales Market Share by igitumab 2012-2017
        2.3.2 United States Insulin Like Growth Factor I Revenue Market Share by igitumab 2012-2017
        2.3.3 United States Insulin Like Growth Factor I Price by igitumab 2012-2017
        2.3.4 
        2.3.5 
    2.4 Insulin Like Growth Factor I, by 6 2012-2017
        2.4.1 United States Insulin Like Growth Factor I Sales Market Share by 6 2012-2017
        2.4.2 United States Insulin Like Growth Factor I Revenue Market Share by 6 2012-2017
        2.4.3 United States Insulin Like Growth Factor I Price by 6 2012-2017
        2.4.4 
        2.4.5 
    2.5 Insulin Like Growth Factor I, by 10.27 2012-2017
        2.5.1 United States Insulin Like Growth Factor I Sales Market Share by 10.27 2012-2017
        2.5.2 United States Insulin Like Growth Factor I Revenue Market Share by 10.27 2012-2017
        2.5.3 United States Insulin Like Growth Factor I Price by 10.27 2012-2017
        2.5.4 
        2.5.5 
    2.6 Insulin Like Growth Factor I, by 30 2012-2017
        2.6.1 United States Insulin Like Growth Factor I Sales Market Share by 30 2012-2017
        2.6.2 United States Insulin Like Growth Factor I Revenue Market Share by 30 2012-2017
        2.6.3 United States Insulin Like Growth Factor I Price by 30 2012-2017
        2.6.4 
        2.6.5 

Chapter Three Insulin Like Growth Factor I by Regions 2012-2017
    3.1 Global Insulin Like Growth Factor I Sales Market Share by Regions 2012-2017
    3.2 Global Insulin Like Growth Factor I Revenue Market Share by Regions 2012-2017
    3.3 Global Insulin Like Growth Factor I Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Insulin Like Growth Factor I by Companies 2012-2017
    4.1 Global Insulin Like Growth Factor I Sales Volume Market Share by Companies 2012-2017
    4.2 Global Insulin Like Growth Factor I Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Insulin Like Growth Factor I Key Product Model and Market Performance
    4.4 Global Top Companies Insulin Like Growth Factor I Key Target Consumers and Market Performance

Chapter Five United States Insulin Like Growth Factor I by Companies 2012-2017
    5.1 United States Insulin Like Growth Factor I Sales Volume Market Share by Companies 2012-2017
    5.2 United States Insulin Like Growth Factor I Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Insulin Like Growth Factor I Key Product Model and Market Performance
    5.4 United States Top Companies Insulin Like Growth Factor I Key Target Consumers and Market Performance

Chapter Six Global Insulin Like Growth Factor I by Consumer 2012-2017
    6.1 Global Insulin Like Growth Factor I Sales Market Share by Consumer 2012-2017
    6.2 Alzheimer's Disease
    6.3 Breast Cancer
    6.4 Huntington Disease
    6.5 Muscular Dystrophy
    6.6 Others
    6.7 Consuming Habit and Preference

Chapter Seven Global Insulin Like Growth Factor I by Consumer 2012-2017
    7.1 Global Insulin Like Growth Factor I Sales Market Share by Consumer 2012-2017
    7.2 Alzheimer's Disease
    7.3 Breast Cancer
    7.4 Huntington Disease
    7.5 Muscular Dystrophy
    7.6 Others
    7.7 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 Boehringer Ingelheim GmbH
        8.1.1 Boehringer Ingelheim GmbH Company Details and Competitors
        8.1.2 Boehringer Ingelheim GmbH Key Insulin Like Growth Factor I Models and Performance
        8.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Business SWOT Analysis and Forecast
        8.1.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
    8.2 Genervon Biopharmaceuticals LLC
        8.2.1 Genervon Biopharmaceuticals LLC Company Details and Competitors
        8.2.2 Genervon Biopharmaceuticals LLC Key Insulin Like Growth Factor I Models and Performance
        8.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Business SWOT Analysis and Forecast
        8.2.4 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
    8.3 MedImmune LLC
        8.3.1 MedImmune LLC Company Details and Competitors
        8.3.2 MedImmune LLC Key Insulin Like Growth Factor I Models and Performance
        8.3.3 MedImmune LLC Insulin Like Growth Factor I Business SWOT Analysis and Forecast
        8.3.4 MedImmune LLC Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
    8.4 Regulaxis SAS
        8.4.1 Regulaxis SAS Company Details and Competitors
        8.4.2 Regulaxis SAS Key Insulin Like Growth Factor I Models and Performance
        8.4.3 Regulaxis SAS Insulin Like Growth Factor I Business SWOT Analysis and Forecast
        8.4.4 Regulaxis SAS Insulin Like Growth Factor I Sales Volume Revenue Price Cost and Gross Margin
    ...

Chapter Nine Industry Chain and Supply Chain
    9.1 Insulin Like Growth Factor I Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Insulin Like Growth Factor I Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Insulin Like Growth Factor I Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Insulin Like Growth Factor I Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by Regions (2017-2022)
    10.3 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by Application (2017-2022)
    10.4 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by B-845 (2017-2022)
    10.5 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by igitumab (2017-2022)
    10.6 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 6 (2017-2022)
    10.7 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 10.27 (2017-2022)
    10.8 Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 30 (2017-2022)

Chapter Eleven United States Insulin Like Growth Factor I Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Insulin Like Growth Factor I Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by Regions (2017-2022)
    11.3 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by B-845 (2017-2022)
    11.5 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by igitumab (2017-2022)
    11.6 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 6 (2017-2022)
    11.7 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 10.27 (2017-2022)
    11.8 United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 30 (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Table Global Insulin Like Growth Factor I Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Insulin Like Growth Factor I Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global Insulin Like Growth Factor I Sales (K Pcs) by B-845 (2012-2017)
    Table Global Insulin Like Growth Factor I Sales Market Share by B-845 (2012-2017)
    Figure Global Insulin Like Growth Factor I Sales Market Share by B-845 in 2016
    Table Global Insulin Like Growth Factor I Revenue (Million USD) by B-845 (2012-2017)
    Table Global Insulin Like Growth Factor I Revenue Market Share by B-845 (2012-2017)
    Figure Global Insulin Like Growth Factor I Revenue Market Share by B-845 in 2016
    Table Global Insulin Like Growth Factor I Price (USD/Pcs) by B-845 (2012-2017)
    Table Global Insulin Like Growth Factor I Sales (K Pcs) by igitumab (2012-2017)
    Table Global Insulin Like Growth Factor I Sales Market Share by igitumab (2012-2017)
    Figure Global Insulin Like Growth Factor I Sales Market Share by igitumab in 2016
    Table Global Insulin Like Growth Factor I Revenue (Million USD) by igitumab (2012-2017)
    Table Global Insulin Like Growth Factor I Revenue Market Share by igitumab (2012-2017)
    Figure Global Insulin Like Growth Factor I Revenue Market Share by igitumab in 2016
    Table Global Insulin Like Growth Factor I Price (USD/Pcs) by igitumab (2012-2017)
    Table Global Insulin Like Growth Factor I Sales (K Pcs) by 6 (2012-2017)
    Table Global Insulin Like Growth Factor I Sales Market Share by 6 (2012-2017)
    Figure Global Insulin Like Growth Factor I Sales Market Share by 6 in 2016
    Table Global Insulin Like Growth Factor I Revenue (Million USD) by 6 (2012-2017)
    Table Global Insulin Like Growth Factor I Revenue Market Share by 6 (2012-2017)
    Figure Global Insulin Like Growth Factor I Revenue Market Share by 6 in 2016
    Table Global Insulin Like Growth Factor I Price (USD/Pcs) by 6 (2012-2017)
    Table Global Insulin Like Growth Factor I Sales (K Pcs) by 10.27 (2012-2017)
    Table Global Insulin Like Growth Factor I Sales Market Share by 10.27 (2012-2017)
    Figure Global Insulin Like Growth Factor I Sales Market Share by 10.27 in 2016
    Table Global Insulin Like Growth Factor I Revenue (Million USD) by 10.27 (2012-2017)
    Table Global Insulin Like Growth Factor I Revenue Market Share by 10.27 (2012-2017)
    Figure Global Insulin Like Growth Factor I Revenue Market Share by 10.27 in 2016
    Table Global Insulin Like Growth Factor I Price (USD/Pcs) by 10.27 (2012-2017)
    Table Global Insulin Like Growth Factor I Sales (K Pcs) by 30 (2012-2017)
    Table Global Insulin Like Growth Factor I Sales Market Share by 30 (2012-2017)
    Figure Global Insulin Like Growth Factor I Sales Market Share by 30 in 2016
    Table Global Insulin Like Growth Factor I Revenue (Million USD) by 30 (2012-2017)
    Table Global Insulin Like Growth Factor I Revenue Market Share by 30 (2012-2017)
    Figure Global Insulin Like Growth Factor I Revenue Market Share by 30 in 2016
    Table Global Insulin Like Growth Factor I Price (USD/Pcs) by 30 (2012-2017)
    Figure United States Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Insulin Like Growth Factor I Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table United States Insulin Like Growth Factor I Sales (K Pcs) by B-845 (2012-2017)
    Table United States Insulin Like Growth Factor I Sales Market Share by B-845 (2012-2017)
    Figure United States Insulin Like Growth Factor I Sales Market Share by B-845 in 2016
    Table United States Insulin Like Growth Factor I Revenue (Million USD) by B-845 (2012-2017)
    Table United States Insulin Like Growth Factor I Revenue Market Share by B-845 (2012-2017)
    Figure United States Insulin Like Growth Factor I Revenue Market Share by B-845 in 2016
    Table United States Insulin Like Growth Factor I Price (USD/Pcs) by B-845 (2012-2017)
    Table United States Insulin Like Growth Factor I Sales (K Pcs) by igitumab (2012-2017)
    Table United States Insulin Like Growth Factor I Sales Market Share by igitumab (2012-2017)
    Figure United States Insulin Like Growth Factor I Sales Market Share by igitumab in 2016
    Table United States Insulin Like Growth Factor I Revenue (Million USD) by igitumab (2012-2017)
    Table United States Insulin Like Growth Factor I Revenue Market Share by igitumab (2012-2017)
    Figure United States Insulin Like Growth Factor I Revenue Market Share by igitumab in 2016
    Table United States Insulin Like Growth Factor I Price (USD/Pcs) by igitumab (2012-2017)
    Table United States Insulin Like Growth Factor I Sales (K Pcs) by 6 (2012-2017)
    Table United States Insulin Like Growth Factor I Sales Market Share by 6 (2012-2017)
    Figure United States Insulin Like Growth Factor I Sales Market Share by 6 in 2016
    Table United States Insulin Like Growth Factor I Revenue (Million USD) by 6 (2012-2017)
    Table United States Insulin Like Growth Factor I Revenue Market Share by 6 (2012-2017)
    Figure United States Insulin Like Growth Factor I Revenue Market Share by 6 in 2016
    Table United States Insulin Like Growth Factor I Price (USD/Pcs) by 6 (2012-2017)
    Table United States Insulin Like Growth Factor I Sales (K Pcs) by 10.27 (2012-2017)
    Table United States Insulin Like Growth Factor I Sales Market Share by 10.27 (2012-2017)
    Figure United States Insulin Like Growth Factor I Sales Market Share by 10.27 in 2016
    Table United States Insulin Like Growth Factor I Revenue (Million USD) by 10.27 (2012-2017)
    Table United States Insulin Like Growth Factor I Revenue Market Share by 10.27 (2012-2017)
    Figure United States Insulin Like Growth Factor I Revenue Market Share by 10.27 in 2016
    Table United States Insulin Like Growth Factor I Price (USD/Pcs) by 10.27 (2012-2017)
    Table United States Insulin Like Growth Factor I Sales (K Pcs) by 30 (2012-2017)
    Table United States Insulin Like Growth Factor I Sales Market Share by 30 (2012-2017)
    Figure United States Insulin Like Growth Factor I Sales Market Share by 30 in 2016
    Table United States Insulin Like Growth Factor I Revenue (Million USD) by 30 (2012-2017)
    Table United States Insulin Like Growth Factor I Revenue Market Share by 30 (2012-2017)
    Figure United States Insulin Like Growth Factor I Revenue Market Share by 30 in 2016
    Table United States Insulin Like Growth Factor I Price (USD/Pcs) by 30 (2012-2017)
    Table Global Insulin Like Growth Factor I Sales (K Pcs) by Regions (2012-2017)
    Table Global Insulin Like Growth Factor I Sales Share by Regions (2012-2017)
    Figure Global Insulin Like Growth Factor I Sales Market Share by Regions in 2016
    Figure Global Insulin Like Growth Factor I Sales Market Share by Regions in 2017
    Table Global Insulin Like Growth Factor I Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global Insulin Like Growth Factor I Revenue Market Share by Regions (2012-2017)
    Figure Global Insulin Like Growth Factor I Revenue Market Share by Regions in 2016
    Figure Global Insulin Like Growth Factor I Revenue Market Share by Regions in 2017
    Table Global Insulin Like Growth Factor I Price (USD/Pcs) by Regions (2012-2017)
    Table North America Insulin Like Growth Factor I Sales (K Pcs) by Regions (2012-2017)
    Table North America Insulin Like Growth Factor I Revenue (Million USD) by Regions (2012-2017)
    Figure North America Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Insulin Like Growth Factor I Sales (K Pcs) by Regions (2012-2017)
    Table United States Insulin Like Growth Factor I Revenue (Million USD) by Regions (2012-2017)
    Figure United States Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America Insulin Like Growth Factor I Sales (K Pcs) by Regions (2012-2017)
    Table Latin America Insulin Like Growth Factor I Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Insulin Like Growth Factor I Sales (K Pcs) by Regions (2012-2017)
    Table Europe Insulin Like Growth Factor I Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific Insulin Like Growth Factor I Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific Insulin Like Growth Factor I Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East Insulin Like Growth Factor I Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East Insulin Like Growth Factor I Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Insulin Like Growth Factor I Sales Volume (K Pcs) by Major Companies (2012-2017)
    Table Global Insulin Like Growth Factor I Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global Insulin Like Growth Factor I Sales Volume Market Share by Major Companies 2016
    Figure Global Insulin Like Growth Factor I Sales Volume Market Share by Major Companies 2017
    Table Global Insulin Like Growth Factor I Revenue (Million USD) by Major Companies (2012-2017)
    Table Global Insulin Like Growth Factor I Revenue Market Share by Major Companies (2012-2017)
    Figure Global Insulin Like Growth Factor I Revenue Market Share by Major Companies 2016
    Figure Global Insulin Like Growth Factor I Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States Insulin Like Growth Factor I Sales Volume (K Pcs) by Top Companies (2012-2017)
    Table United States Insulin Like Growth Factor I Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States Insulin Like Growth Factor I Sales Volume Market Share by Top Companies 2016
    Figure United States Insulin Like Growth Factor I Sales Volume Market Share by Top Companies 2017
    Table United States Insulin Like Growth Factor I Revenue (Million USD) by Top Companies (2012-2017)
    Table United States Insulin Like Growth Factor I Revenue Market Share by Top Companies (2012-2017)
    Figure United States Insulin Like Growth Factor I Revenue Market Share by Top Companies 2016
    Figure United States Insulin Like Growth Factor I Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global Insulin Like Growth Factor I Sales (K Pcs) by Consumer (2012-2017)
    Figure Global Insulin Like Growth Factor I Sales Market Share by Consumer (2012-2017)
    Figure Global Insulin Like Growth Factor I Sales Market Share by Consumer in 2016
    Figure Global Alzheimer's Disease Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Breast Cancer Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Huntington Disease Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Muscular Dystrophy Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Others Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Insulin Like Growth Factor I Sales (K Pcs) by Consumer (2012-2017)
    Figure United States Insulin Like Growth Factor I Sales Market Share by Consumer (2012-2017)
    Figure United States Insulin Like Growth Factor I Sales Market Share by Consumer in 2016
    Figure United States Alzheimer's Disease Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Breast Cancer Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Huntington Disease Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Muscular Dystrophy Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Others Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (2012-2017)
    Table Boehringer Ingelheim GmbH Company Details and Competitors
    Table Boehringer Ingelheim GmbH Key Insulin Like Growth Factor I Models and Performance
    Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Business SWOT Analysis and Forecast
    Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales Market Share (%) in Global (2012-2017)
    Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor I Revenue Market Share (%) in Global (2012-2017)
    Table Genervon Biopharmaceuticals LLC Company Details and Competitors
    Table Genervon Biopharmaceuticals LLC Key Insulin Like Growth Factor I Models and Performance
    Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Business SWOT Analysis and Forecast
    Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales Market Share (%) in Global (2012-2017)
    Figure Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Revenue Market Share (%) in Global (2012-2017)
    Table MedImmune LLC Company Details and Competitors
    Table MedImmune LLC Key Insulin Like Growth Factor I Models and Performance
    Table MedImmune LLC Insulin Like Growth Factor I Business SWOT Analysis and Forecast
    Table MedImmune LLC Insulin Like Growth Factor I Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure MedImmune LLC Insulin Like Growth Factor I Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure MedImmune LLC Insulin Like Growth Factor I Sales Market Share (%) in Global (2012-2017)
    Figure MedImmune LLC Insulin Like Growth Factor I Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure MedImmune LLC Insulin Like Growth Factor I Revenue Market Share (%) in Global (2012-2017)
    Table Regulaxis SAS Company Details and Competitors
    Table Regulaxis SAS Key Insulin Like Growth Factor I Models and Performance
    Table Regulaxis SAS Insulin Like Growth Factor I Business SWOT Analysis and Forecast
    Table Regulaxis SAS Insulin Like Growth Factor I Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Regulaxis SAS Insulin Like Growth Factor I Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Regulaxis SAS Insulin Like Growth Factor I Sales Market Share (%) in Global (2012-2017)
    Figure Regulaxis SAS Insulin Like Growth Factor I Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Regulaxis SAS Insulin Like Growth Factor I Revenue Market Share (%) in Global (2012-2017)
    Figure Global Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Insulin Like Growth Factor I Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Insulin Like Growth Factor I Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales Volume Share Forecast by Regions in 2022
    Table Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales Volume Market Share Forecast by Application in 2022
    Table Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by B-845 (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by B-845 (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales Volume Market Share Forecast by B-845 in 2022
    Table Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by igitumab (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by igitumab (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales Volume Market Share Forecast by igitumab in 2022
    Table Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 6 (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 6 (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales Volume Market Share Forecast by 6 in 2022
    Table Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 10.27 (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 10.27 (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales Volume Market Share Forecast by 10.27 in 2022
    Table Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 30 (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales (K Pcs) Forecast by 30 (2017-2022)
    Figure Global Insulin Like Growth Factor I Sales Volume Market Share Forecast by 30 in 2022
    Figure United States Insulin Like Growth Factor I Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure United States Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Insulin Like Growth Factor I Price (USD/Pcs) Trend Forecast (2017-2022)
    Table United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by Regions (2017-2022)
    Table United States Insulin Like Growth Factor I Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales Volume Share Forecast by Regions in 2022
    Table United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by Application (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales Volume Market Share Forecast by Application in 2022
    Table United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by B-845 (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by B-845 (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales Volume Market Share Forecast by B-845 in 2022
    Table United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by igitumab (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by igitumab (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales Volume Market Share Forecast by igitumab in 2022
    Table United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 6 (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 6 (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales Volume Market Share Forecast by 6 in 2022
    Table United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 10.27 (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 10.27 (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales Volume Market Share Forecast by 10.27 in 2022
    Table United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 30 (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales (K Pcs) Forecast by 30 (2017-2022)
    Figure United States Insulin Like Growth Factor I Sales Volume Market Share Forecast by 30 in 2022